ID
35644
Descripción
Study ID: 103268 Clinical Study ID: 103268 Study Title: An Open Label, Randomised, Single Dose, Three-way Crossover Study to Investigate the Relative Bioavailability of Two Different Formulations of GSK163090 and the Effect of Food on the Pharmacokinetics of a Tablet Formulation in Healthy Male and Female Volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00536679 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK163090 capsule, fasted/fed Trade Name: N/A Study Indication: Depression; Depressive Disorder and Anxiety Disorders
Palabras clave
Versiones (1)
- 13/3/19 13/3/19 -
Titular de derechos de autor
GSK group of companies
Subido en
13 de marzo de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
the Effect of Food on the Pharmacokinetics of a Tablet Formulation - 103268
Adverse Events
- StudyEvent: ODM
Descripción
Serious Adverse Event
Descripción
SECTION 1
Alias
- UMLS CUI-1
- C1828479
- UMLS CUI-2
- C1519255
Descripción
Record one SAE diagnosis per line, or a sign/symptom if the diagnosis is not available. If a diagnosis subsequently becomes available, this then should be entered and the sign/symptom crossed out, initialled and dated by the investigator. A separate form should be used for each SAE. However, if multiple SAEs which are temporally or clinically related are apparent at the time of initial reporting then these may be reported on the same page.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0011900
Descripción
Record the start date of the first occurrence of the SAE.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1519255
Descripción
Record the start date of the first occurrence of the SAE.
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C1519255
Descripción
All SAEs must be followed until the events are resolved, the condition stabilises, the events are otherwise explained, or the subject is lost to follow-up. Indicate if the event was ’Recovered/Resolved’ or ’Recovered/Resolved with sequelae’. If the SAE is ongoing at the time the subject completes the study or becomes lost to follow-up, the outcome must be recorded as ’Not recovered/Not resolved’ or ’Recovering/Resolving’. Also enter ’Not recovered/Not resolved’ if the SAE was ongoing at the time of death, but was not the cause of death, enter fatal for the SAE which was the direct cause of death.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1705586
- UMLS CUI [1,2]
- C1519255
Descripción
Record the end date. This is the date the SAE Recovered/Resolved, or if the outcome was fatal, record the date the subject died. If the event Recovered/ Resolved with sequelae, enter the date the subject’s medical condition resolved or stabilised. Leave blank if the SAE is ’Not recovered/Not resolved’ or ’Recovering/Resolving’.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C1519255
Descripción
Record the end time of the SAE.
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C1519255
Descripción
Record the maximum intensity that occurred over the duration of the event. Amend the intensity if it increases. Mild = An event that is easily tolerated by the subject, causing minimal discomfort and not interfering with everyday activities. Moderate = An event that is sufficiently discomforting to interfere with everyday activities. Severe = An event that prevents normal everyday activities. Not applicable = Those event(s) where intensity is meaningless or impossible to determine (i.e., blindness and coma).
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C1519255
Descripción
Investigational product(s) withdrawn = Dose reduced = Dose increased = Dose not changed = Dose interrupted = Not applicable = Administration of investigational product(s) was permanently discontinued. Dose is reduced for one or more investigational product(s). Dose increased for one or more investigational product(s). Investigational product(s) continues even though an adverse event has occurred. Administration of one or more investigational product(s) was temporarily interrupted but then restarted. Subject was not receiving investigational product(s) when the event occurred (e.g., pre-or post-dosing) or the subject died and there was no prior decision to discontinue IP(s).
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1704758
- UMLS CUI [1,2]
- C1519255
Descripción
Indicate ’Yes’ if the event(s) were directly responsible for the subject’s withdrawal as indicated on the Study Conclusion page, otherwise indicate ’No’. If yes: Complete Study Conclusion page and check Adverse event as reason for withdrawal.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1519255
Descripción
It is a regulatory requirement for investigators to assess relationship to investigational product(s) based on information available. The assessment should be reviewed on receipt of any new information and amended if necessary. ’A reasonable possibility’ is meant to convey that there are facts/evidence or arguments to suggest a causal relationship. Facts/evidence or arguments that may support ’a reasonable possibility’ include, e.g., a temporal relationship, a pharmacologically-predicted event, or positive dechallenge or rechallenge. Confounding factors, such as concomitant medication, a concurrent illness, or relevant medical history, should also be considered.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C1519255
Descripción
Section 2: Seriousness
Descripción
SAE results in death
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0011065
Descripción
SAE is life-threatening
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826244
Descripción
SAE requires hospitalisation
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0019993
Descripción
SAE results in disability/incapacity
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0231170
Descripción
Congenital anomaly/birth defect
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0000768
Descripción
Óther SAE
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C1880177
Descripción
Other SAE specificationn
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3845569
Descripción
SECTION 3: Demography Data
Alias
- UMLS CUI-1
- C0011298
- UMLS CUI-2
- C1828479
Descripción
SECTION 4
Alias
- UMLS CUI-1
- C1828479
Descripción
Section 5
Alias
- UMLS CUI-1
- C0015127
- UMLS CUI-2
- C1519255
Descripción
Possible Causes of SAE Other Than Investigational Product(s)
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0015127
- UMLS CUI [1,2]
- C1519255
Descripción
If
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2348235
- UMLS CUI [1,2]
- C0012634
Descripción
If "Concomitant medication(s)", specify:
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2348235
- UMLS CUI [1,2]
- C2347852
Descripción
If "Other", specify:
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2348235
Descripción
SECTION 6: RELEVANT Medical Conditions
Alias
- UMLS CUI-1
- C0262926
Descripción
Relevant Medical Conditions
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0262926
- UMLS CUI [1,3]
- C1519255
Descripción
Date of onset
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0574845
Descripción
continuation SAE
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0805733
- UMLS CUI [1,2]
- C1519255
Descripción
Date of Last Occurrence
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C2745955
Descripción
Section 7
Descripción
SECTION 8 RELEVANT Concomitant Medications
Alias
- UMLS CUI-1
- C1828479
- UMLS CUI-2
- C2347852
Descripción
Drug Name
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
Dose
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C3174092
Descripción
Unit
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1519795
Descripción
Frequency
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3476109
Descripción
Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Taken Prior to Study?
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826667
Descripción
Start Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0808070
Descripción
Stop Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0806020
Descripción
Ongoing Medication?
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826666
Descripción
Reason for Medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013227
Descripción
Section 9 - Investigational Product
Descripción
Section 10
Descripción
Details of relevant assessments
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1261322
- UMLS CUI [1,2]
- C1519255
Descripción
SECTION 11 Narrative Remarks
Alias
- UMLS CUI-1
- C1828479
- UMLS CUI-2
- C0947611
Descripción
Investigator's signature
Alias
- UMLS CUI-1
- C2346576
Descripción
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2346576
Descripción
Investigator signature date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Descripción
Investigator name
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826892
Similar models
Adverse Events
- StudyEvent: ODM
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1880177 (UMLS CUI [1,2])
C1828479 (UMLS CUI-2)
C0034897 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0262926 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C2347852 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0947611 (UMLS CUI-2)
C1519255 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])